SwePub
Sök i SwePub databas

  form:Ext_t

Träfflista för sökning "WFRF:(Wolk A) "

form:Search_simp_t: WFRF:(Wolk A)

  • navigation:Result_t 1-10 navigation:of_t 536
hitlist:Modify_result_t
   
hitlist:Enumeration_thitlist:Reference_thitlist:Reference_picture_thitlist:Find_Mark_t
1.
  • Jiang, X., et al. (creator_code:aut_t)
  • Shared heritability and functional enrichment across six solid cancers
  • 2019
  • record:In_t: Nature Communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 10
  • swepub:Mat_article_t (swepub:level_refereed_t)abstract
    • Quantifying the genetic correlation between cancers can provide important insights into the mechanisms driving cancer etiology. Using genome-wide association study summary statistics across six cancer types based on a total of 296,215 cases and 301,319 controls of European ancestry, here we estimate the pair-wise genetic correlations between breast, colorectal, head/neck, lung, ovary and prostate cancer, and between cancers and 38 other diseases. We observed statistically significant genetic correlations between lung and head/neck cancer (r(g) = 0.57, p = 4.6 x 10(-8)), breast and ovarian cancer (r(g) = 0.24, p = 7 x 10(-5)), breast and lung cancer (r(g) = 0.18, p = 1.5 x 10(-6)) and breast and colorectal cancer (r(g) = 0.15, p = 1.1 x 10(-4)). We also found that multiple cancers are genetically correlated with non-cancer traits including smoking, psychiatric diseases and metabolic characteristics. Functional enrichment analysis revealed a significant excess contribution of conserved and regulatory regions to cancer heritability. Our comprehensive analysis of cross-cancer heritability suggests that solid tumors arising across tissues share in part a common germline genetic basis.
  •  
2.
  •  
3.
  • Figlioli, G, et al. (creator_code:aut_t)
  • The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
  • 2019
  • record:In_t: NPJ breast cancer. - : Springer Science and Business Media LLC. - 2374-4677. ; 5, s. 38-
  • swepub:Mat_article_t (swepub:level_refereed_t)abstract
    • Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are associated with breast cancer risk. FANCM, which encodes for a DNA translocase, has been proposed as a breast cancer predisposition gene, with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We tested the three recurrent protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and p.Arg1931* for association with breast cancer risk in 67,112 cases, 53,766 controls, and 26,662 carriers of pathogenic variants of BRCA1 or BRCA2. These three variants were also studied functionally by measuring survival and chromosome fragility in FANCM−/− patient-derived immortalized fibroblasts treated with diepoxybutane or olaparib. We observed that FANCM:p.Arg658* was associated with increased risk of ER-negative disease and TNBC (OR = 2.44, P = 0.034 and OR = 3.79; P = 0.009, respectively). In a country-restricted analysis, we confirmed the associations detected for FANCM:p.Arg658* and found that also FANCM:p.Arg1931* was associated with ER-negative breast cancer risk (OR = 1.96; P = 0.006). The functional results indicated that all three variants were deleterious affecting cell survival and chromosome stability with FANCM:p.Arg658* causing more severe phenotypes. In conclusion, we confirmed that the two rare FANCM deleterious variants p.Arg658* and p.Arg1931* are risk factors for ER-negative and TNBC subtypes. Overall our data suggest that the effect of truncating variants on breast cancer risk may depend on their position in the gene. Cell sensitivity to olaparib exposure, identifies a possible therapeutic option to treat FANCM-associated tumors.
  •  
4.
  •  
5.
  •  
6.
  • Vogel, Jacob W., et al. (creator_code:aut_t)
  • Four distinct trajectories of tau deposition identified in Alzheimer’s disease
  • 2021
  • record:In_t: Nature Medicine. - : Springer Science and Business Media LLC. - 1078-8956 .- 1546-170X. ; 27:5, s. 871-881
  • swepub:Mat_article_t (swepub:level_refereed_t)abstract
    • Alzheimer’s disease (AD) is characterized by the spread of tau pathology throughout the cerebral cortex. This spreading pattern was thought to be fairly consistent across individuals, although recent work has demonstrated substantial variability in the population with AD. Using tau-positron emission tomography scans from 1,612 individuals, we identified 4 distinct spatiotemporal trajectories of tau pathology, ranging in prevalence from 18 to 33%. We replicated previously described limbic-predominant and medial temporal lobe-sparing patterns, while also discovering posterior and lateral temporal patterns resembling atypical clinical variants of AD. These ‘subtypes’ were stable during longitudinal follow-up and were replicated in a separate sample using a different radiotracer. The subtypes presented with distinct demographic and cognitive profiles and differing longitudinal outcomes. Additionally, network diffusion models implied that pathology originates and spreads through distinct corticolimbic networks in the different subtypes. Together, our results suggest that variation in tau pathology is common and systematic, perhaps warranting a re-examination of the notion of ‘typical AD’ and a revisiting of tau pathological staging. © 2021, The Author(s), under exclusive licence to Springer Nature America, Inc.
  •  
7.
  •  
8.
  • Matejcic, M, et al. (creator_code:aut_t)
  • Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry
  • 2019
  • record:In_t: Nature communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 10:1, s. 382-
  • swepub:Mat_article_t (swepub:level_refereed_t)abstract
    • The original version of this Article contained an error in the spelling of the author Manuela Gago-Dominguez, which was incorrectly given as Manuela G. Dominguez. This has now been corrected in both the PDF and HTML versions of the Article.
  •  
9.
  •  
10.
  • Beral, V., et al. (creator_code:aut_t)
  • Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies
  • 2012
  • record:In_t: The Lancet Oncology. - 1474-5488. ; 13:9, s. 946-956
  • swepub:Mat_article_t (swepub:level_refereed_t)abstract
    • Background Smoking has been linked to mucinous ovarian cancer, but its effects on other ovarian cancer subtypes and on overall ovarian cancer risk are unclear, and the findings from most studies with relevant data are unpublished. To assess these associations, we review the published and unpublished evidence. Methods Eligible epidemiological studies were identified by electronic searches, review articles, and discussions with colleagues. Individual participant data for 28 114 women with and 94 942 without ovarian cancer from 51 epidemiological studies were analysed centrally, yielding adjusted relative risks (RRs) of ovarian cancer in smokers compared with never smokers. Findings After exclusion of studies with hospital controls, in which smoking could have affected recruitment, overall ovarian cancer incidence was only slightly increased in current smokers compared with women who had never smoked (RR 1.06, 95% CI 1.01-1.11, p=0.01). Of 17 641 epithelial cancers with specified histology, 2314 (13%) were mucinous, 2360 (13%) endometrioid, 969 (5%) clear-cell, and 9086 (52%) serous. Smoking-related risks varied substantially across these subtypes (p(heterogeneity)<0.0001). For mucinous cancers, incidence was increased in current versus never smokers (1.79, 95% CI 1.60-2.00, p<0.0001), but the increase was mainly in borderline malignant rather than in fully malignant tumours (2.25, 95% CI 1.91-2.65 vs 1.49, 1.28-1.73; p(heterogeneity)=0.01; almost half the mucinous tumours were only borderline malignant). Both endometrioid (0.81, 95% CI 0.72-0.92, p=0.001) and clear-cell ovarian cancer risks (0.80, 95% CI 0.65-0.97, p=0.03) were reduced in current smokers, and there was no significant association for serous ovarian cancers (0.99, 95% CI 0.93-1.06, p=0.8). These associations did not vary significantly by 13 sociodemographic and personal characteristics of women including their body-mass index, parity, and use of alcohol, oral contraceptives, and menopausal hormone therapy. Interpretation The excess of mucinous ovarian cancers in smokers, which is mainly of tumours of borderline malignancy, is roughly counterbalanced by the deficit of endometrioid and clear-cell ovarian cancers. The substantial variation in smoking-related risks by tumour subtype is important for understanding ovarian carcinogenesis.
  •  
Skapa referenser, mejla, bekava och länka
  • navigation:Result_t 1-10 navigation:of_t 536
swepub:Mat_t
swepub:mat_article_t (474)
swepub:mat_conferencepaper_t (48)
swepub:mat_researchreview_t (11)
swepub:mat_publicationother_t (3)
swepub:Level_t
swepub:level_refereed_t (450)
swepub:level_scientificother_t (86)
swepub:Hitlist_author_t
Wolk, A (314)
Wolk, Alicja (186)
Giles, Graham G (81)
Hakansson, N. (49)
Giles, GG (47)
Albanes, Demetrius (47)
deldatabas:search_more_t
White, Emily (47)
Brenner, H (46)
Peters, Ulrike (45)
Brenner, Hermann (43)
Haiman, CA (42)
Milne, Roger L. (42)
Chang-Claude, Jenny (41)
John, EM (39)
Zheng, W. (38)
Chang-Claude, J (38)
Easton, DF (38)
Le Marchand, L (36)
Visvanathan, Kala (36)
Zheng, Wei (36)
Gago-Dominguez, M. (36)
Le Marchand, Loïc (35)
Berndt, Sonja I (34)
Larsson, Susanna C. (34)
Rennert, Gad (33)
Kraft, P (33)
Olsson, Håkan (32)
Weiderpass, Elisabet ... (32)
Southey, MC (32)
Dunning, AM (32)
Chanock, SJ (32)
van den Brandt, Piet ... (32)
Neuhausen, SL (32)
Campbell, Peter T. (31)
Hunter, David J (31)
Rennert, G. (31)
Rohan, Thomas E. (31)
Newcomb, Polly A. (30)
Pharoah, Paul D. P. (30)
Albanes, D (30)
Zeleniuch-Jacquotte, ... (30)
Muir, K (29)
Chan, Andrew T. (29)
Buring, Julie E (29)
Milne, RL (28)
Gapstur, Susan M (28)
Hopper, JL (28)
Orsini, N (28)
Moreno, Victor (28)
Wu, Anna H. (28)
deldatabas:search_less_t
swepub:Hitlist_uni_t
swepub_uni:ki_t (412)
swepub_uni:uu_t (281)
swepub_uni:lu_t (46)
swepub_uni:umu_t (44)
swepub_uni:oru_t (26)
swepub_uni:gu_t (17)
deldatabas:search_more_t
swepub_uni:ri_t (3)
swepub_uni:su_t (2)
swepub_uni:mdh_t (2)
swepub_uni:liu_t (2)
swepub_uni:cth_t (1)
swepub_uni:slu_t (1)
deldatabas:search_less_t
hitlist:Language_t
language:Eng_t (535)
language:Swe_t (1)
hitlist:HSV_t
hsv:Cat_3_t (268)
hsv:Cat_1_t (13)
hsv:Cat_2_t (5)
hsv:Cat_4_t (2)
hsv:Cat_5_t (1)

hitlist:Year_t

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt tools:Close_t

tools:Permalink_label_t